Figure 1.
CONSORT diagram showing the number of patients in each part of the trial, therapy given before transplant, and outcomes in each group. CT, chemotherapy; MRD, measurable residual disease; NRM, nonrelapse mortality; REL, relapse; UNK, unknown cause of death.